SPP1 + macrophages cause exhaustion of tumor-specific T cells in liver metastases

Rajiv Trehan(National Institutes of Health), Patrick Huang(National Institutes of Health), Xiao Bin Zhu(National Institutes of Health), Xin Wang(National Institutes of Health), Marlaine Soliman(National Institutes of Health), Dillon Strepay(National Institutes of Health), Amran Nur(National Institutes of Health), Noémi Kedei(National Institutes of Health), Martin Arhin(National Institutes of Health), Shadin Ghabra(National Institutes of Health), Francisco Rodríguez-Matos(National Institutes of Health), Mohamed-Reda Benmebarek(National Institutes of Health), Chi Ma(National Institutes of Health), Firouzeh Korangy(National Institutes of Health), Tim F. Greten(National Institutes of Health)
Nature Communications
May 7, 2025
Cited by 41Open Access
Full Text

Abstract

Functional tumor-specific CD8+ T cells are essential for effective anti-tumor immune response and immune checkpoint inhibitor therapy. Here we show that, compared to other organ sites, primary, metastatic liver tumors in murine models contain a higher number of tumor-specific CD8+ T cells which are also dysfunctional. High-dimensional, multi-omic analysis of patient samples reveals a higher frequency of exhausted tumor-reactive CD8+ T cells and enriched interactions between these cells and SPP1+ macrophages in profibrotic, alpha-SMA rich regions specifically in the liver. Differential pseudotime trajectory inference analysis reveals that extrahepatic signaling promotes an intermediate cell (IC) population in the liver, characterized by co-expression of VISG4, CSF1R, CD163, TGF-βR, IL-6R, and SPP1. Analysis of premetastatic adenocarcinoma patient samples reveals enrichment of this population may predict liver metastasis. These findings suggest a mechanism by which extrahepatic tumors drive liver metastasis by promoting an IC population that inhibits tumor-reactive CD8+ T cell function.


Related Papers

No related papers found

Powered by citation graph analysis